Chemoinformaics analysis of CAMPESTEROL GLUCOSIDE
| Molecular Weight | 562.832 | nRot | 8 |
| Heavy Atom Molecular Weight | 504.368 | nRig | 26 |
| Exact Molecular Weight | 562.423 | nRing | 5 |
| Solubility: LogS | -4.3 | nHRing | 1 |
| Solubility: LogP | 5.584 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 98 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 40 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 58 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 34 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 100.266 |
| nHD | 4 | BPOL | 61.658 |
| QED | 0.293 |
| Synth | 4.951 |
| Natural Product Likeliness | 2.685 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.137 |
| Pgp-sub | 0.005 |
| HIA | 0.02 |
| CACO-2 | -4.796 |
| MDCK | 0.00002 |
| BBB | 0.057 |
| PPB | 0.979776 |
| VDSS | 1.512 |
| FU | 0.0227032 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.339 |
| CYP2c19-inh | 0.008 |
| CYP2c19-sub | 0.908 |
| CYP2c9-inh | 0.038 |
| CYP2c9-sub | 0.161 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.304 |
| CYP3a4-inh | 0.069 |
| CYP3a4-sub | 0.416 |
| CL | 6.257 |
| T12 | 0.018 |
| hERG | 0.027 |
| Ames | 0.076 |
| ROA | 0.057 |
| SkinSen | 0.02 |
| Carcinogencity | 0.05 |
| EI | 0.005 |
| Respiratory | 0.634 |
| NR-Aromatase | 0.071 |
| Antiviral | No |
| Prediction | 0.578274 |